Follow this page and receive
notifications about new suppliers
Levofloxacin API Manufacturers
compare suppliers & get competitive offers
Date | Seller | Exporter country | Buyer | Importer country | Product | Quantity (KG) | Price per KG | Latest transactions |
---|---|---|---|---|---|---|---|---|
30-Sep-2024 | (Hidden) | India | EGYPT PHAR... | Egypt | DRUG & DRU... | 30 | $ @36$-7! | Check all data |
28-Sep-2024 | (Hidden) | India | EGYPT PHAR... | Egypt | DRUG & DRU... | 1,750 | $ @36$-7! | |
28-Sep-2024 | (Hidden) | India | EGYPT PHAR... | Egypt | DRUG & DRU... | 3,000 | $ @36$-7! |
Filters
Reset current filters
Type
Production region
Qualifications
Country of origin
Producer
Established for 17 years and a leading enterprise in China's API industry
Mature technology and advanced production equipment
Quality assurance and fast delivery
+ 0
All certificates
Distributor
Produced in:
Established in: 2005
MOQ: -
Employees: 200+
Portfolio of over 2,000 APIs
Precise quality control
End-to-end global regulatory support
+ 0
All certificates
Distributor
Produced in:
Established in: 2011
MOQ: 1 kg
Employees: 10+
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
+ 0
All certificates
Distributor
Produced in:
Established in: 2019
MOQ: -
Employees: 50+
ISO 9001, SGS, Eurofins certificated supplier.
Audit available either on site or remote.
Professional One Stop Service for delivery to customers.
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
Produced in:
Established in: 1944
MOQ: -
Employees: 4,000
14 international API plant sites
Portfolio of 350+ APIs
Teva is among the world’s largest generic drug/API manufacturers
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
Distributor
+ 0
All certificates
Producer
+ 0
All certificates
Producer
+ 0
All certificates
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Looking for Levofloxacin API 100986-85-4?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Levofloxacin. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Levofloxacin
- Synonyms:
- L-ofloxacin , Levofloxacine , Levofloxacino , Levofloxacinum , Ofloxacin S-(-)-form
- Cas Number:
- 100986-85-4
- DrugBank number:
- DB01137
- Unique Ingredient Identifier:
- RIX4E89Y14
About Levofloxacin
Want to know what Levofloxacin is used for? Levofloxacin is a fluoroquinolone antibiotic and the optical S-(-) isomer of racemic ofloxacin. It reportedly carries 8 to 128-fold more activity against both gram-negative and gram-positive bacteria compared to R-(+)-ofloxacin1 and remains stereochemically stable following administration (i.e. it does not invert to the inactive isomer).
Levofloxacin, along with other quinolones such as gatifloxacin and moxifloxacin, is a member of the third generation of fluoroquinolones, colloquially referred to as the respiratory quinolones due to improved activity against gram-positive bacteria commonly implicated in respiratory infections Levofloxacin was first approved by the FDA in 1996, and was approved in Canada and several South American countries soon after.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.
Levofloxacin is a type of Quinolones
Quinolones belong to a vital subcategory of pharmaceutical active pharmaceutical ingredients (APIs). They are a group of synthetic antibiotics that possess a broad-spectrum activity against various bacterial infections. This technical description will shed light on the key characteristics and applications of quinolones.
Quinolones exhibit potent bactericidal activity by targeting DNA gyrase and topoisomerase IV, which are essential enzymes for bacterial DNA replication and repair. This mechanism of action distinguishes quinolones from other classes of antibiotics, making them effective against both Gram-positive and Gram-negative bacteria.
The versatility of quinolones enables their application in the treatment of a wide range of infections, including respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections, and sexually transmitted diseases. Furthermore, they have proven efficacy against bacteria resistant to other antibiotics, making them indispensable in clinical practice.
Pharmaceutical companies utilize advanced manufacturing processes to synthesize quinolones with high purity and quality. Stringent quality control measures ensure the safety and efficacy of these APIs, complying with regulatory standards.
Quinolones have revolutionized the field of antibacterial therapy, providing healthcare professionals with potent tools to combat bacterial infections. However, it is crucial to utilize them judiciously to prevent the emergence of antibiotic resistance.
In conclusion, quinolones, as a subcategory of pharmaceutical APIs, possess remarkable antibacterial properties, making them invaluable in the treatment of various infections. Their broad-spectrum activity, mechanism of action, and effectiveness against resistant bacteria make quinolones a crucial component of modern healthcare.
Levofloxacin (Quinolones), classified under Anti-infective Agents
Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.
Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.
The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.
The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.
In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.
Levofloxacin manufacturers | traders | suppliers
We have 34 companies offering Levofloxacin produced in 8 different countries.
Get in contact with the supplier of your choice:
- Xi'an ZB Biotech Co., Ltd from China, product country of origin China
- LGM Pharma from United States, product country of origin World
- Shandong Octagon Chemicals Limited from China, product country of origin China
- Aurora Industry Co., Ltd from China, product country of origin China
- Unnati Pharmaceuticals Pvt Ltd from India, product country of origin India
- Dongbang FTL from South Korea, product country of origin South Korea
- Zhejiang Starry from China, product country of origin China
- Daiichi Sankyo from Japan, product country of origin Japan
- Kolon Life Science from South Korea, product country of origin South Korea
- Teva API from Israel, product country of origin Unknown
- Jiangxi Chenyang from China, product country of origin China
- Iwaki Seiyaku from Japan, product country of origin Japan
- K. Sevantilal & Co. from India, product country of origin India
- HEC Pharm from Germany, product country of origin Unknown
- Zhejiang East Asia Pharmaceutical from China, product country of origin China
- Chemi S.p.A. from Italy, product country of origin Brazil
- TURTLE PHARMA from India, product country of origin India
- Alfresa Fine Chemical from Japan, product country of origin Japan
- Ildong Pharmaceutical from South Korea, product country of origin South Korea
- Yuhan Chemical from South Korea, product country of origin South Korea
- Quimica Sintetica from Spain, product country of origin Unknown
- Ranbaxy Laboratories from India, product country of origin India
- Zhejiang East-Asia Pharma from China, product country of origin China
- Shangyu Jingxin from China, product country of origin China
- Humble Healthcaare from India, product country of origin India
- Zhejiang Tiantai from China, product country of origin China
- Chemo Iberica from Spain, product country of origin Spain
- MSN Life Sciences from India, product country of origin India
- Sun Pharma from India, product country of origin India
- Mylan from India, product country of origin India
- Hetero Drugs from India, product country of origin India
- Shaoxing Hantai Pharma from China, product country of origin China
- Cipla from India, product country of origin India
- Lupin from India, product country of origin India
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.